Vaccines - STAT

Health By Lev Facher and Nicholas Florko

How David beat Goliath: Advocacy groups seized a moment, and found allies, in bid to loosen vaccine patent rights

Biotech By Jonathan Saltzman — Boston Globe

Moderna’s CEO says he ‘didn’t lose a minute of sleep’ over potential waiver of vaccine patents

The Readout LOUD By Damian Garde, Meg Tirrell, and Adam Feuerstein

Listen: Vaccine riches, patent waivers, & a gene therapy for aging

Pharmalot By Ed Silverman

Pharmalittle: Biden supports WTO proposal on Covid-19 vaccine IP; Biogen Alzheimer’s drug is cost-effective at $2,500

First Opinion By Judith Chevalier and Jason L. Schwartz

Dollar stores: gateways to equitable Covid-19 vaccine distribution

Health By Damian Garde, Helen Branswell, and Matthew Herper

Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive

Pharmalot By Ed Silverman

Pharmalittle: Pharma showers a key Democratic senator with cash; Lilly exec accused of altering factory documents

Pharmalot By Megan Thielking

STAT+ Conversations: An update from STAT’s Pharmalot

Pharmalot By Ed Silverman

Brazilian senate votes to suspend patents in bid to widen access to Covid-19 vaccines

Health By Alicia Diaz

Door knocking works to get information to immigrant communities. Why aren’t more places using it for Covid-19?

Pharmalot By Ed Silverman

U.K. lawmakers want Boris Johnson to disclose emails with pharma about a WTO proposal on Covid-19 vaccines

Health By Helen Branswell

U.S. lifts pause on use of J&J’s Covid-19 vaccine

Pharmalot By Ed Silverman

Millions sign petitions urging the U.S. to back a WTO proposal for greater Covid-19 vaccine access

Health By Andrew Joseph

States with springtime Covid-19 surges appear to have turned a corner

Pharmalot By Ed Silverman

FDA issues scathing report of Emergent plant responsible for contaminated Covid-19 vaccines

Pharmalot By Ed Silverman

Most Americans say they should be vaccinated before the U.S. donates Covid-19 shots elsewhere

Pharmalot By Ed Silverman

Congress probes Emergent’s ties to a key Trump official in wake of Covid-19 vaccine scandal

First Opinion By Stephen M. Tourjee

Catching Covid-19 after being vaccinated isn’t a myth. It happened to me

Exclusive By Nicholas Florko

Biden officials met privately with 3M, AmerisourceBergen, PhRMA, and more to debate shoring up the national stockpile

Health By Helen Branswell

We know a lot about Covid-19. Experts have many more questions

Pharmalot By Ed Silverman

Pharmalittle: J&J rivals rebuff bid to jointly study Covid-19 vaccine risks; will next-gen Covid shots be better or worse?

Health By Helen Branswell

Next-generation Covid-19 vaccines are supposed to be better. Some experts worry they could be worse

The Readout LOUD By Damian Garde, Meg Tirrell, and Adam Feuerstein

Listen: J&J’s vaccine pause, how to talk about remote risks, & why we don’t have new drugs for Covid-19

Pharmalot By Ed Silverman

WTO head urges movement on controversial Covid-19 vaccine proposal, but objections remain

First Opinion By Ethan Dmitrovsky

Most Read

Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson

U.S. will back proposal to waive intellectual property rights and boost Covid-19 vaccine production

Virologist Angela Rasmussen on the controversy surrounding Russia’s Sputnik V Covid-19 vaccine

India is suffering immensely under the weight of Covid. Now its failures are threatening much of the world

Why would a Covid vaccine cause rare blood clots? Researchers have found clues

Shattering the infertility myth: What we know about Covid-19 vaccines and pregnancy

‘Authorization’ status is a red herring when it comes to mandating Covid-19 vaccination

Vaccinations are plateauing. Don’t blame it on ‘resistance’

All Coverage

How David beat Goliath: Advocacy groups seized a moment, and found allies, in bid to loosen vaccine patent rights

Moderna’s CEO says he ‘didn’t lose a minute of sleep’ over potential waiver of vaccine patents

Listen: Vaccine riches, patent waivers, & a gene therapy for aging

Pharmalittle: Biden supports WTO proposal on Covid-19 vaccine IP; Biogen Alzheimer’s drug is cost-effective at $2,500

Dollar stores: gateways to equitable Covid-19 vaccine distribution

Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive

Pharmalittle: Pharma showers a key Democratic senator with cash; Lilly exec accused of altering factory documents

STAT+ Conversations: An update from STAT’s Pharmalot

Brazilian senate votes to suspend patents in bid to widen access to Covid-19 vaccines

Door knocking works to get information to immigrant communities. Why aren’t more places using it for Covid-19?

U.K. lawmakers want Boris Johnson to disclose emails with pharma about a WTO proposal on Covid-19 vaccines

U.S. lifts pause on use of J&J’s Covid-19 vaccine

Millions sign petitions urging the U.S. to back a WTO proposal for greater Covid-19 vaccine access

States with springtime Covid-19 surges appear to have turned a corner

FDA issues scathing report of Emergent plant responsible for contaminated Covid-19 vaccines

Most Americans say they should be vaccinated before the U.S. donates Covid-19 shots elsewhere

Congress probes Emergent’s ties to a key Trump official in wake of Covid-19 vaccine scandal

Catching Covid-19 after being vaccinated isn’t a myth. It happened to me

Biden officials met privately with 3M, AmerisourceBergen, PhRMA, and more to debate shoring up the national stockpile

We know a lot about Covid-19. Experts have many more questions

Pharmalittle: J&J rivals rebuff bid to jointly study Covid-19 vaccine risks; will next-gen Covid shots be better or worse?

Next-generation Covid-19 vaccines are supposed to be better. Some experts worry they could be worse

Listen: J&J’s vaccine pause, how to talk about remote risks, & why we don’t have new drugs for Covid-19

WTO head urges movement on controversial Covid-19 vaccine proposal, but objections remain

Rethinking triage in an era of vaccine nationalism